Literature DB >> 32125557

Does persistent use of radiation in women > 70 years of age with early-stage breast cancer reflect tailored patient-centered care?

Lauren J Taylor1, Jennifer S Steiman2, Bethany Anderson3,4, Jessica R Schumacher1, Lee G Wilke1,4, Caprice C Greenberg1,4, Heather B Neuman5,6,7.   

Abstract

PURPOSE: Randomized controlled trials demonstrate that omission of radiation therapy (RT) in older women with early-stage cancer undergoing breast conserving surgery (BCS) is an "acceptable choice." Despite this, high RT rates have been reported. The objective was to evaluate the impact of patient- and system-level factors on RT rates in a contemporary cohort.
METHODS: Through the National Cancer Data Base, we identified women with clinical stage I estrogen receptor-positive breast cancer who underwent BCS (n = 84,214). Multivariable logistic regression identified patient, tumor, and system-level factors associated with RT. Joinpoint regression analysis calculated trends in RT use over time stratified by age and facility-type, reporting annual percent change (APC).
RESULTS: RT rates decreased from 2004 (77.2%) to 2015 (64.3%). The decline occurred earliest and was most pronounced in older women treated at academic facilities. At academic facilities, the APC was - 5.6 (95% CI - 8.6, - 2.4) after 2009 for women aged > 85 years, - 6.4 (95% CI - 9.0, - 3.8) after 2010 for women aged 80 -  < 85 years, - 3.7 (95% CI - 5.6, - 1.9) after 2009 for women aged 75 -  < 80, and - 2.4 (95% CI, - 3.1, - 1.6) after 2009 for women aged 70 -  < 75. In contrast, at community facilities rates of RT declined later (2011, 2012, and 2013 for age groups 70-74, 75-79, and 80-84 years).
CONCLUSIONS: RT rates for older women with early-stage breast cancer are declining with patient-level variation based on factors related to life expectancy and locoregional recurrence. Facility-level variation suggests opportunities to improve care delivery by focusing on barriers to de-implementation of routine use of RT.

Entities:  

Keywords:  Breast cancer; Breast conserving therapy; De-escalation; Elderly; Lumpectomy; Radiation

Mesh:

Substances:

Year:  2020        PMID: 32125557      PMCID: PMC7474974          DOI: 10.1007/s10549-020-05579-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

Review 1.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

2.  Conceptualizing De-Implementation in Cancer Care Delivery.

Authors:  Wynne E Norton; David A Chambers; Barnett S Kramer
Journal:  J Clin Oncol       Date:  2018-11-08       Impact factor: 44.544

3.  The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer.

Authors:  Charles E Rutter; Nataniel H Lester-Coll; Brandon R Mancini; Christopher D Corso; Henry S Park; Debra N Yeboa; Cary P Gross; Suzanne B Evans
Journal:  Cancer       Date:  2015-03-24       Impact factor: 6.860

4.  Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Authors:  Ian H Kunkler; Linda J Williams; Wilma J L Jack; David A Cameron; J Michael Dixon
Journal:  Lancet Oncol       Date:  2015-01-28       Impact factor: 41.316

5.  Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: practice patterns at National Comprehensive Cancer Network institutions.

Authors:  Beryl McCormick; Rebecca A Ottesen; Melissa E Hughes; Sara H Javid; Seema A Khan; Joanne Mortimer; Joyce C Niland; Jane C Weeks; Stephen B Edge
Journal:  J Am Coll Surg       Date:  2014-06-06       Impact factor: 6.113

6.  Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.

Authors:  Samantha M Buszek; Heather Y Lin; Isabelle Bedrosian; Nina Tamirisa; Gildy V Babiera; Yu Shen; Simona F Shaitelman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-08-01       Impact factor: 7.038

7.  The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343.

Authors:  Manisha Palta; Priya Palta; Nrupen A Bhavsar; Janet K Horton; Rachel C Blitzblau
Journal:  Cancer       Date:  2014-12-08       Impact factor: 6.860

8.  Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.

Authors:  Richard Pötter; Michael Gnant; Werner Kwasny; Christoph Tausch; Leonore Handl-Zeller; Brigitte Pakisch; Susanne Taucher; Josef Hammer; Gero Luschin-Ebengreuth; Marianne Schmid; Felix Sedlmayer; Michael Stierer; Georg Reiner; Karin Kapp; Friedrich Hofbauer; Andrea Rottenfusser; Sabine Pöstlberger; Karin Haider; Wolfgang Draxler; Raimund Jakesz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-23       Impact factor: 7.038

9.  Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.

Authors:  Quyen D Chu; Meijiao Zhou; Kaelen L Medeiros; Prakash Peddi; Xiao Cheng Wu
Journal:  Anticancer Res       Date:  2017-10       Impact factor: 2.480

10.  Estimating average annual per cent change in trend analysis.

Authors:  Limin X Clegg; Benjamin F Hankey; Ram Tiwari; Eric J Feuer; Brenda K Edwards
Journal:  Stat Med       Date:  2009-12-20       Impact factor: 2.373

View more
  7 in total

1.  Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.

Authors:  Elaine McKevitt; Rona Cheifetz; Kimberly DeVries; Alison Laws; Rebecca Warburton; Lovedeep Gondara; Caroline Lohrisch; Alan Nichol
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

2.  Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.

Authors:  Brooke C Bredbeck; Nicole M Mott; Ton Wang; Brandy R Sinco; Tasha M Hughes; Hari Nathan; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2022-04-05       Impact factor: 5.344

3.  Using Tailored Messages to Target Overuse of Low-Value Breast Cancer Care in Older Women.

Authors:  Lesly A Dossett; Nicole M Mott; Brooke C Bredbeck; Ton Wang; Chad Tc Jobin; Tasha M Hughes; Sarah T Hawley; Brian J Zikmund-Fisher
Journal:  J Surg Res       Date:  2021-11-19       Impact factor: 2.192

4.  Age and Breast Reconstruction.

Authors:  Luis Chang-Azancot; Pedro Abizanda; María Gijón; Nitzan Kenig; Manuel Campello; Jessica Juez; Antonio Talaya; Gregorio Gómez-Bajo; Javier Montón; Rodrigo Sánchez-Bayona
Journal:  Aesthetic Plast Surg       Date:  2022-08-04       Impact factor: 2.708

5.  Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.

Authors:  Ton Wang; Alison Baskin; Jacquelyn Miller; Allan Metz; Niki Matusko; Tasha Hughes; Michael Sabel; Jacqueline S Jeruss; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

6.  Gaps in Online Breast Cancer Treatment Information for Older Women.

Authors:  Alison S Baskin; Ton Wang; Nicole M Mott; Sarah T Hawley; Reshma Jagsi; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-07-30       Impact factor: 5.344

7.  Patient Perspectives on Treatment Options for Older Women With Hormone Receptor-Positive Breast Cancer: A Qualitative Study.

Authors:  Ton Wang; Nicole Mott; Jacquelyn Miller; Nicholas L Berlin; Sarah Hawley; Reshma Jagsi; Lesly A Dossett
Journal:  JAMA Netw Open       Date:  2020-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.